EZNome
Berkeley
About EZNome
EZNome commercializes high-throughput mammalian genome editing technologies. The company was founded in 2018 by Sean Chen and is based in Berkeley, California, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Non-Equity Assistance (Sep 2018)
Industries & Categories
Biotechnology, Genetics
Canonical: https://fsome.com/organization/eznome-534871 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.